Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: a scoping review.
Article in JBI Evidence Synthesis (July 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Insulin degludec/insulin aspart therapy after intensive insulin therapy with the diabetic patient with poorly controlled of blood glucose by oral medication and insulin glargine: a case report
Article in Chinese Journal of Diabetes Mellitus (June 2024)
Efficacy and Safety of Insulin Degludec/Insulin Aspart versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
Article in Iranian Journal of Public Health (February 2024)